申请人:Zhou Dahui
                            
                            
                                公开号:US20080293771A1
                            
                            
                                公开(公告)日:2008-11-27
                            
                            The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the histamine-3 receptor
                            本发明提供了一种I式化合物及其用于治疗与或受到
组胺-3受体相关的中枢神经系统疾病的用途。